FDA authorises first direct-to-consumer test for BRCA mutations, with caveats

March 6, 2018
Research and Development, Sales and Marketing 23andME, BRCA, Cancer, FDA, breast cancer, ovarian cancer, pharma

The FDA has given its authorisation to the first ever direct-to-consumer (DTC) test to identify three BRCA gene mutations which …

gilead_hq_at_stockley_park_london

Switching to Gilead’s Biktarvy proves non-inferior in HIV patients

March 6, 2018
Manufacturing and Production, Research and Development Biktarvy, Gilead, HIV, pharma

Gilead has unveiled findings from two Phase 3 studies into the efficacy of switching to its three-drug combo Biktarvy (bictegravir/emtricitabine/tenofovir …

University of Adelaide is fighting antibiotic-resistant superbugs by starving them of iron

March 6, 2018
Manufacturing and Production, Research and Development Adelaide, Australia, Superbugs, antibiotic resistance, pharma

A team of researchers from Australia’s University of Adelaide have developed a new method to fighting antibiotic-resistant bacteria by starving …

martin_shkreli_2016

Martin Shkreli ordered to forfeit $7.36m ahead of fraud sentencing

March 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Martin Shkreli, pharma

Reviled pharma bro Martin Shkreli is experiencing another heavy dose of karma after a US judge ordered him to forfeit …

dermira_logo

Dermira terminates acne drug after Phase 3 failure, wiping $667m from market value

March 5, 2018
Manufacturing and Production, Research and Development Dermira, acne, pharma, trial failure

Skin specialist biopharma firm Dermira has seen its stock crash and burn following the announcement that it plans to terminate …

gilead-sciences

Gilead investigational data gives hope for HIV eradication in humans

March 5, 2018
Research and Development, Sales and Marketing Gilead, HIV, pharma

Gilead has lifted the curtain on new preclinical data on the efficacy of a combo therapy of GS-9620, its investigational …

FDA finds major manufacturing issues at key Aurobindo facility

March 5, 2018
Manufacturing and Production, Sales and Marketing Aurobindo, FDA, pharma

Indian pharmaceutical firm Aurobindo has been rocked by an USFDA review which identified nine major issues with its Unit 4 …

celgene_1_02

Celgene strikes $101m partnership in oncology, neurodegenerative and inflammatory

March 5, 2018
Research and Development, Sales and Marketing Cancer, Celgene, Vividion, inflammatory, neurodegenerative, oncology, pharma

Celgene has inked a new multi-year partnership with biotech firm Vividion Therapeutics to leverage the latter’s proteomics and chemistry platforms …

mri_credit_-_ptrump16

NHS trials “world-leading” initiative to cut prostate cancer diagnoses to just days

March 5, 2018
Research and Development, Sales and Marketing Cancer, MRI, NHS, pharma, prostate cancer

The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than …

Abbvie and Biogen pull MS drug Zinbryta following urgent EMA safety review

March 5, 2018
Sales and Marketing AQbbvie, Biogen, EMA, Europe, mulyiple sclerosis, pharma, zinbryta

Biogen and Abbvie have announced their intention to voluntarily withdraw their multiple sclerosis therapy Zinbryta (daclizumab) from all global markets …

endo-international

Endo granted injunction to block blood pressure competitor

March 2, 2018
Medical Communications, Sales and Marketing Endo, QuVa, Vasostrict, blood pressure, pharma, vasopressin

Generics and speciality pharma firm Endo International has revealed that it has been granted a preliminary injunction to block  competitor …

diabetes-2424105_960_720

Study identifies five kinds of diabetes, potentially changing treatment

March 2, 2018
Medical Communications, Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

A decade-long study has unearthed findings that could entirely change how people living with diabetes are treated, after the classic …

shutterstock_92671375

Artificial Cell Technologies CFO accused of stealing nearly $1m in company funds

March 2, 2018
Medical Communications, Sales and Marketing Artificial Cell Technologies, cfo, pharma

A high-ranking C-level executive of a US biotech start-up has been charged with embezzling almost $1 million from the company …

phone_health

Novartis forms a Pear to develop mobile therapies

March 2, 2018
Medical Communications, Research and Development Novartis, Pear Therapeutics, biotech, drugs, pharma, pharmaceutical

Novartis has announced an agreement between Pear Therapeutics and itself to develop two digital therapeutics, one in schizophrenia and one …

david_meek_web

Ipsen: Becoming a “development powerhouse”

March 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Insider Interview, ipsen, pharma

Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …

takeda_usa_pharmaceuticals_u

Takeda to create 70 jobs with €25m Dublin investment

March 1, 2018
Manufacturing and Production Dublin, Takeda, pharma

Takeda has announced its investment of €25 million to construct a new “modular cell therapy facility dedicated to manufacturing a …

11149low_reception_in_darm

Merck/Pfizer’s Bavencio wins slight reprieve after NICE nod

March 1, 2018
Medical Communications, Sales and Marketing Bavencio, Merck, Pfizer, biotech, drugs, pharma, pharmaceutical

Just two weeks ago, Merck KGaA and Pfizer were hit with a major setback for their PD-L1 immunotherapy, Bavencio, after …

The Gateway to Local Adoption Series

Latest content